CRISPR Therapeutics
CRSP
$55.66
Share price
1.11%
Change (1 day)
8.97%
Change (1 year)
EPS for CRISPR Therapeutics (CRSP)
EPS in 2023 (TTM): -$5.30
According to CRISPR Therapeutics's latest financial reports the company's current EPS (TTM) is -$5.30. In 2022 the company made an earnings per share (EPS) of -$8.37 a decrease over its 2021 EPS that were of $4.99.
EPS history for CRISPR Therapeutics from 2016 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$5.30 | -36.68% |
| 2022 | -$8.37 | -267.74% |
| 2021 | $4.99 | -194.33% |
| 2020 | -$5.29 | -576.58% |
| 2019 | $1.11 | -132.36% |
| 2018 | -$3.43 | 100.58% |
| 2017 | -$1.71 | 159.42% |
| 2016 | -$0.66 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$2.18 | -58.87% | 🇺🇸 USA |